Fig. 3
From: New agents and regimens for diffuse large B cell lymphoma
Established and emerging immune checkpoint targets in DLBCL and corresponding blocking monoclonal antibodies as immune checkpoint inhibitors
Fig. 3 | Journal of Hematology & Oncology